Cervical cancer is one of the commonest cancer cause of death among women worldwide. >80% of all the cervical cancer cases are found in developing and low-resource countries, because of a lack of awareness and difficulty in running cytology-based screening programs. Conventional Pap smear testin...
The article reports that Pap smear screening of elderly women is an effective and relatively low-cost method for lowering cervical cancer death rates. This is particularly true among high-risk i...
Results of the first screening round of the Canadian Cervical Cancer, did not support the assumption that HPV testing is less specific than Pap smear. While, a study published in a medical journal reveals that the addition of HPV testing to Pap smear lessens the incidence of lesions or cancer...
The Taiwanese government launched a nationwide cervical screening program in July of 1995, in which annual Pap smear screenings were offered to women aged over 30 years. According to current reports in Taiwan, the annual compliance rate for Pap testing is approximately 30% by age 60, which ...
Results of the first screening round of the Canadian Cervical Cancer, did not support the assumption that HPV testing is less specific than Pap smear. While, a study published in a medical journal reveals that the addition of HPV testing to Pap smear lessens the incidence of lesions or cancer...
OBJECTIVES: To assess empirically the relationships between the utilization of recommended preventive services and different forms of patient cost-sharing and how the effect is mediated by type of preventive service (counseling, blood pressure, Pap smear, mammogram), type of cost-sharing (deductibles/...
An intrauterine device (IUD) is a small T-shaped plastic birth control device inserted into the uterus during a brief procedure in a doctor's office. There are two types of IUD -- one uses copper and the other, progestin -- and the copper IUD is popular among women who want a non-ho...
Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system To evaluate the long-term cost-effectiveness of different strategies for human papillomavirus (HPV) DNA testing combined with Pap smear for cervical cancer...
Among the tests conducted was a pap smear, which is generally only recommended for much younger women, not an octogenarian who was already dying of liver and heart disease. "In medicine we have turned the laws of supply and demand upside down," Elliot Fisher said. "Supply drives its own ...
In the context of current screening patterns, vaccination of 12-year old Canadian females with an ASO4-ajuvanted cervical cancer vaccine is estimated to significantly reduce cervical cancer and mortality, and is a cost-effective option. However, the economic attractiveness of vaccination is impacted...